Short answer · Medically reviewed summary · Last updated: 2023-07-13
Felty Syndrome is a rare autoimmune disorder that primarily affects individuals with longstanding rheumatoid arthritis (RA). While the exact prevalence of Felty Syndrome is not well-established, it is estimated to occur in approximately 1-3% of individuals with RA. Felty Syndrome is characterized by the triad of rheumatoid arthritis, an enlarged spleen (splenomegaly), and a low white blood cell count (neutropenia).
What is the prevalence of Felty Syndrome?
Prevalence of Felty Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Felty Syndrome is a rare autoimmune disorder that primarily affects individuals with longstanding rheumatoid arthritis (RA). While the exact prevalence of Felty Syndrome is not well-established, it is estimated to occur in approximately 1-3% of individuals with RA.
Felty Syndrome is characterized by the triad of rheumatoid arthritis, an enlarged spleen (splenomegaly), and a low white blood cell count (neutropenia). The condition typically develops after several years of RA and is more commonly observed in individuals with severe, long-standing RA.
Although Felty Syndrome is considered rare, it is important to note that prevalence rates may vary across different populations and geographic regions. The condition predominantly affects adults, with a higher incidence in females than males.
Diagnosis of Felty Syndrome involves clinical evaluation, blood tests to assess white blood cell count and autoantibodies, as well as imaging studies to evaluate the spleen. Treatment options aim to manage the symptoms and complications, including medications to control RA and prevent infections.
While Felty Syndrome poses challenges due to its rarity, ongoing research and advancements in autoimmune disorders continue to shed light on this condition, leading to improved understanding, diagnosis, and management strategies.
